| イスラエル | トルコ | オーストリア | |
| 幹細胞療法 | から $7,500 | から $4,675 | から $8,500 |
| 臍帯血幹細胞療法 | から $14,500 | から $5,000 | から $7,500 |
| 膝の幹細胞治療 | から $5,500 | から $3,500 | から $12,000 |
| 幹細胞療法 | から $19,500 | から $6,000 | から $20,000 |
| 幹細胞療法 | から $18,500 | から $15,000 | から $20,000 |
Bookimedは幹細胞療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで幹細胞療法代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。幹細胞療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。幹細胞療法の旅路でお一人になることはありません。
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.
She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.
Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.
Stem cell therapy is legal in Israel and overseen by the Ministry of Health. As a global pioneer in regenerative medicine, Israel permits approved treatments like bone marrow transplants, CAR T-cell therapy, and autologous stem cell applications for orthopedic conditions within licensed medical centers.
Bookimed Expert Insight: Data shows a clear distinction between experimental trials and established orthopedic use. For example, Dr. Ron Arbel at Sourasky Medical Center (Ichilov) applies stem cells for biological reconstruction of joints. Patients often choose Israel for these procedures because top-tier clinics manage 400,000+ patients annually with high success rates.
Patient Consensus: Patients emphasize that treatment legitimacy depends on the specific medical condition and cell source. Many advise verifying if a procedure is part of a registered hospital protocol rather than a private wellness package.
Israel regulates stem cell clinics through a centralized framework managed by the Ministry of Health. All laboratories manufacturing cells must hold valid licenses and adhere to Good Manufacturing Practice standards. Facilities typically operate within accredited hospital systems like Sourasky Medical Center to ensure strict biosafety compliance.
Bookimed Expert Insight: While hospital-based centers like Sourasky or Hadassah follow rigorous clinical trial protocols, some standalone clinics operate in a regulatory gray area. Patients should prioritize doctors like Dr. Ron Arbel who lead formal clinical investigations. Selecting a specialist at a major academic center ensures your treatment uses traceable, university-vetted cell processing protocols.
Patient Consensus: Patients emphasize that the laboratory's certification matters more than the injection itself. They advise verifying if a clinic uses autologous bone-marrow or donor-derived products before starting treatment.
Leading medical centers in Israel for stem-cell therapy include Sourasky Medical Center (Ichilov), Sheba Medical Center, and Hadassah Medical Center. These JCI-accredited institutions utilize state-of-the-art biological reconstruction, CAR T-cell therapy, and regenerative orthopedic protocols to treat complex oncological, neurological, and musculoskeletal conditions within high-tech research environments.
Bookimed Expert Insight: While many search for experimental trials, Sourasky (Ichilov) has standardized regenerative orthopedic care. Their packages, starting at $6,340, include specialized consultations and follow-ups. This is highly efficient for international patients compared to the $10,400 US average. Focus on centers where surgeons also serve national sports teams for the most proven outcomes.
Patient Consensus: Patients emphasize choosing major university-affiliated hospitals over standalone marketing clinics. They recommend verifying whether the treatment is a standard clinical protocol or an experimental trial before arrival.
Israeli treatment programmes primarily use adult stem cells, focusing on mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs). High-tech facilities like Sourasky Medical Center and Hadassah utilize autologous bone marrow concentrate, umbilical cord tissue, and placental-derived biologics for orthopedic, neurological, and oncological therapies.
Bookimed Expert Insight: While many countries offer general stem cell injections, Israeli protocols often integrate advanced delivery systems. Specialists like Dr. Ron Arbel at Sourasky Medical Center combine biological reconstruction with Orthokine or robotic-assisted delivery. This targeted approach ensures higher cell concentration at the injury site, potentially improving cartilage regeneration outcomes compared to standard IV infusions.
Patient Consensus: Patients emphasize verifying the exact cell source, such as bone marrow versus adipose tissue, before starting treatment. They often recommend requesting lab reports and GMP certifications to confirm cell counts and processing quality.
Medical travel packages for stem-cell therapy in Israel typically include specialist consultations, laboratory blood tests, and medical transfers. Most bundles feature diagnostic screenings like complete blood counts and imaging, followed by the therapeutic injection and language assistance from a dedicated medical coordinator.
Bookimed Expert Insight: Israeli clinics like Sourasky Medical Center often distinguish between standard stem cell injections and Orthokine treatments. While injections are outpatient with 0 hospital nights, the $500 price difference in packages often reflects additional medications and multiple orthopedic consultations required for biological reconstruction.
Patient Consensus: Patients emphasize the need to confirm the exact number of treatment sessions and whether MRI evaluations are pre-included or billed separately after arrival. Most value the direct coordination with board-certified specialists who manage both the procedure and long-term remote following.